Private equity firms Actis Capital and Sequoia Capital are planning to sell a controlling stake in FMCG company Paras Pharmaceuticals Limited for $700 million.The private equity firms decided to sell their shares after receiving interest from drugmakers including GlaxoSmithKline, Sanofi-Aventis and Abbott Laboratories.
Actis, a private equity firm that invests in emerging markets, holds about 62% in Paras and Sequoia holds about 8%, while Paras Chairman Girish Patel and employees own the remaining stake.
Transaction Reference: BS
Century Real Estate Holdings, the real estate arm of the Century Group has raised Rs.100 crore though private placement of NCDs last week.
Strengthening its foothold in Africa, Maharashtra Hybrid Seeds Company has picked up a 60% stake in Zimbabwe-based seed firm, Quton Seed Company, for an undisclosed sum.